Evolutionary Mechanisms of Persistence and Diversification of a Calicivirus Within Endemically Infected Natural Host Populations
Overview
Affiliations
In order to understand the evolutionary mechanisms of persistence and diversification within the Caliciviridae, we have been exploiting endemic infection of feline calicivirus within five geographically distinct household groups of cats. By sequencing immunodominant and variable regions of the capsid gene, we identified the relative contribution of the different evolutionary processes employed by the virus to ensure its long-term survival in the host population. Such strategies included progressive evolution of a given variant of a strain through mutation accumulation within an individual, sequential reinfection with either a variant of the same strain or with a different strain, and mixed infection. Recombination between different strains in this study has been reported in detail elsewhere (K. P. Coyne et al., J. Gen. Virol. 87:921-926, 2006). Here, we provide evidence to suggest that true long-term persistent infection in individuals is relatively rare, with the majority of apparent viral carriers undergoing a combination of progressive evolution and cyclical reinfection. Progressive evolution at the individual level and variant reinfection at both the individual and population levels were associated with positive selection. Two measures of evolution rate were determined; for a virus progressively evolving within an individual (1.32 x 10(-2) to 2.64 x 10(-2) substitutions per nucleotide per year, i.e., no transmission) and for a strain circulating within a population (3.84 x 10(-2) to 4.56 x 10(-2) substitutions per nucleotide per year, i.e., including transmission). Reiteration of both progressive evolution and variant reinfection appeared to lead to a gradual increase in the diversity of a given strain of virus, both in the individual and in the population, until eventually new strains emerged.
Epidemiology and Molecular Characterization of Feline Calicivirus in Beijing, China.
Wang D, Zhu J, Yang H, Lyu Y Animals (Basel). 2025; 15(4).
PMID: 40002976 PMC: 11852138. DOI: 10.3390/ani15040494.
Screening and Immune Efficacy Evaluation of Antigens with Protection Against Feline Calicivirus.
Yang Y, Qi R, Chen M, Feng K, Liu Z, Kang H Vaccines (Basel). 2024; 12(11).
PMID: 39591108 PMC: 11598032. DOI: 10.3390/vaccines12111205.
Molecular epidemiology and strain diversity of circulating feline Calicivirus in Thai cats.
Phongroop K, Rattanasrisomporn J, Piewbang C, Tangtrongsup S, Rungsipipat A, Techangamsuwan S Front Vet Sci. 2024; 11:1377327.
PMID: 38887538 PMC: 11180889. DOI: 10.3389/fvets.2024.1377327.
Update on feline calicivirus: viral evolution, pathogenesis, epidemiology, prevention and control.
Wei Y, Zeng Q, Gou H, Bao S Front Microbiol. 2024; 15:1388420.
PMID: 38756726 PMC: 11096512. DOI: 10.3389/fmicb.2024.1388420.
Isolation and molecular characteristics of a recombinant feline calicivirus from Qingdao, China.
Liu Y, Qin L, Hu X, Jiang Y Vet Res Forum. 2024; 14(11):583-588.
PMID: 38169473 PMC: 10758007. DOI: 10.30466/vrf.2023.1975795.3701.